Home Healthcare Biotechnology Proteinase K Market

Proteinase K Market Size, Share & Trends Analysis Report By Foam (Lyophilized Powder Form, Liquid Form), By Therapeutic Area (Infectious Diseases, Oncology, Cardiology, Autoimmune Diseases, Neurology, Others), By Applications (Purification of DNA & RNA, In situ Hybridization, Mitochondria Isolation, Enzyme Removal), By End-User (Biotechnology Companies, Contract Research Organization, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Proteinase K Market, By Foam 2022-2034 (USD MILLION/ Units)
    1. Lyophilized Powder Form
    2. Liquid Form
  2. Proteinase K Market, By Therapeutic Area 2022-2034 (USD MILLION/ Units)
    1. Infectious Diseases
    2. Oncology
    3. Cardiology
    4. Autoimmune Diseases
    5. Neurology
    6. Others
  3. Proteinase K Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Purification of DNA & RNA 
    2. In situ Hybridization 
    3. Mitochondria Isolation 
    4. Enzyme Removal 
  4. Proteinase K Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Biotechnology Companies
    2. Contract Research Organization
    3. Others
  5. Regional Proteinase K Market
    1. North America
      1. North America Proteinase K Market By Foam 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder Form
        2. Liquid Form
      2. North America Proteinase K Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Infectious Diseases
        2. Oncology
        3. Cardiology
        4. Autoimmune Diseases
        5. Neurology
        6. Others
      3. North America Proteinase K Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Purification of DNA & RNA 
        2. In situ Hybridization 
        3. Mitochondria Isolation 
        4. Enzyme Removal 
      4. North America Proteinase K Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biotechnology Companies
        2. Contract Research Organization
        3. Others
      5. U.S.
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      6. Canada
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
    2. Europe
      1. Europe Proteinase K Market By Foam 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder Form
        2. Liquid Form
      2. Europe Proteinase K Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Infectious Diseases
        2. Oncology
        3. Cardiology
        4. Autoimmune Diseases
        5. Neurology
        6. Others
      3. Europe Proteinase K Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Purification of DNA & RNA 
        2. In situ Hybridization 
        3. Mitochondria Isolation 
        4. Enzyme Removal 
      4. Europe Proteinase K Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biotechnology Companies
        2. Contract Research Organization
        3. Others
      5. U.K.
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      6. Germany
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      7. France
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      8. Spain
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      9. Italy
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      10. Russia
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      11. Nordic
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      12. Benelux
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      13. Rest of Europe
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
    3. APAC
      1. APAC Proteinase K Market By Foam 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder Form
        2. Liquid Form
      2. APAC Proteinase K Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Infectious Diseases
        2. Oncology
        3. Cardiology
        4. Autoimmune Diseases
        5. Neurology
        6. Others
      3. APAC Proteinase K Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Purification of DNA & RNA 
        2. In situ Hybridization 
        3. Mitochondria Isolation 
        4. Enzyme Removal 
      4. APAC Proteinase K Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biotechnology Companies
        2. Contract Research Organization
        3. Others
      5. China
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      6. Korea
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      7. Japan
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      8. India
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      9. Australia
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      10. Taiwan
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      11. South East Asia
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      12. Rest of Asia-Pacific
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
    4. Middle East and Africa
      1. Middle East and Africa Proteinase K Market By Foam 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder Form
        2. Liquid Form
      2. Middle East and Africa Proteinase K Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Infectious Diseases
        2. Oncology
        3. Cardiology
        4. Autoimmune Diseases
        5. Neurology
        6. Others
      3. Middle East and Africa Proteinase K Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Purification of DNA & RNA 
        2. In situ Hybridization 
        3. Mitochondria Isolation 
        4. Enzyme Removal 
      4. Middle East and Africa Proteinase K Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biotechnology Companies
        2. Contract Research Organization
        3. Others
      5. UAE
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      6. Turkey
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      7. Saudi Arabia
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      8. South Africa
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      9. Egypt
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      10. Nigeria
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      11. Rest of MEA
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
    5. LATAM
      1. LATAM Proteinase K Market By Foam 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder Form
        2. Liquid Form
      2. LATAM Proteinase K Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Infectious Diseases
        2. Oncology
        3. Cardiology
        4. Autoimmune Diseases
        5. Neurology
        6. Others
      3. LATAM Proteinase K Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Purification of DNA & RNA 
        2. In situ Hybridization 
        3. Mitochondria Isolation 
        4. Enzyme Removal 
      4. LATAM Proteinase K Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biotechnology Companies
        2. Contract Research Organization
        3. Others
      5. Brazil
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      6. Mexico
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      7. Argentina
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      8. Chile
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      9. Colombia
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
      10. Rest of LATAM
        1. Lyophilized Powder Form
        2. Liquid Form
        3. Infectious Diseases
        4. Oncology
        5. Cardiology
        6. Autoimmune Diseases
        7. Neurology
        8. Others
        9. Purification of DNA & RNA 
        10. In situ Hybridization 
        11. Mitochondria Isolation 
        12. Enzyme Removal 
        13. Biotechnology Companies
        14. Contract Research Organization
        15. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.